StonvexLoading…
StonvexStonvexStonvexCore line items from ASC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $310.20M | $405.78M | $395.98M | $445.74M |
Operating Income | $41.56M | $137.74M | $118.28M | $138.86M |
Net Income | $41.01M | $133.01M | $116.81M | $138.45M |
EPS (Diluted) | $0.88 | $3.06 | $2.71 | $3.52 |
Total Assets | $788.72M | $704.80M | $690.95M | $723.86M |
Total Liabilities | $154.39M | $69.38M | $116.51M | $217.42M |
Cash & Equivalents | $46.84M | $46.99M | $46.80M | $50.57M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 40.73M | 40.46M | 41.30M | 40.63M |